Bicycle Therapeutics PLC (NASDAQ:BCYC)
| 21.43 BATS BZX Real-Time Price As of 3:18pm ET |  -0.69 / -3.12%Today’s Change | 12.08 Today|||52-Week Range 62.08 | -64.79% Year-to-Date |
Latest BCYC News | Press Releases
No recent news for Bicycle Therapeutics PLC.
Today’s Trading
| Previous close | 22.12 |
| Today’s open | 21.41 |
| Day’s range | 21.41 - 21.91 |
| Volume | 2,006 |
| Average volume (3 months) | 277,609 |
| Market cap | $692.6M |
Data as of 3:18pm ET, 10/07/2022
Growth & Valuation
| Earnings growth (last year) | +0.71% |
| Earnings growth (this year) | -41.65% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +11.70% |
| P/E ratio | NM |
| Price/Sales | 130.43 |
| Price/Book | 1.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACETAdicet Bio Inc | -0.55 | -3.51% |
| NKTRNektar Therapeutics | +0.13 | +4.01% |
| NSTGNanoString Technolog... | -1.63 | -12.00% |
| BNGOBionano Genomics Inc | -0.20 | -9.26% |
Data as of 3:19pm ET, 10/07/2022
Financials
| Next reporting date | November 3, 2022 |
| EPS forecast (this quarter) | -$0.90 |
| Annual revenue (last year) | $11.7M |
| Annual profit (last year) | -$66.8M |
| Net profit margin | -571.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
